查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829509

一次性生物製程市场（按产品类型、工作流程阶段、生物处理模式、应用和终端用户划分）—2025-2032 年全球预测

Single-use Bioprocessing Market by Product Type, Workflow Stage, Bioprocess Mode, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年一次性生物製程市场规模将成长至 597.7 亿美元，复合年增长率为 16.19%。

主要市场统计数据
基准年2024年 179.9亿美元
预计2025年 208.1亿美元
预测年份：2032年 597.7亿美元
复合年增长率（%） 16.19%

一次性生物製程技术以及推动全球生物製造领导者做出策略决策的市场动态的高阶主管介绍

一次性生物製程已从实验室方法发展成为生技药品开发和商业化生产的核心製造模式。近期趋势——技术改进、监管机构对一次性技术的认可以及营运重点的变化——加速了开发商、合约服务供应商和成熟製药商的兴趣。本介绍概述了一次性系统如今的重要性。一次性系统可降低交叉污染的风险，实现快速的宣传活动週期，并提供模组化设计以支援灵活的生产布局。

当企业在速度需求与严格的品管之间寻求平衡时，一次性解决方案的利弊需要仔细评估。资本规划、材料供应可靠性以及与现有不銹钢资产的整合是影响实施时间表的实际考虑因素。引言还预览了分析过程中反覆出现的主题，包括生命週期永续性、数位仪器和感测器、填充-精加工的去中心化，以及供应商作为系统整合商而非组件供应商的角色演变。

读者会发现，评估技术不仅要孤立地进行，更要将其置于更广泛的生物製造生态系统中，才能明确价值所在和风险所在。后续章节将在此基础上，探讨推动技术应用的变革性转变、贸易政策变化的影响、需求的细微细分，以及经营团队在製定一次性策略时必须考虑的区域和竞争动态。

再形成一次性生物製程的新技术和营运曲折点，包括数位整合、模组化设计和永续性驱动因素

在技​​术、监管和商业性力量融合的推动下，一次性生物製程领域正经历一段转型期。材料科学和感测器微型化的进步正在提升一次性组件的可靠性和分析能力，从而实现更严格的製程控制和更可重复的结果。同时，包括增强的连接性、嵌入式探头和远端监控在内的数位整合正在使一次性系统与现代自动化框架相容，从而降低了在受监管的生产环境中部署的门槛。

营运模式也在改变。製造商不再投资大型、固定容量的不銹钢设备，而是青睐模组化、撬装的解决方案，这些解决方案可以横向扩展以满足不断变化的需求。这种变化支持快速的产品生命週期转换和合约製造安排，在这些安排中，快速转换和短期灵活性至关重要。永续性问题和生命週期评估方法正在重新强调在可行的情况下重复使用材料，同时也认识到一次性用品在契约製造空间内可以节省能源和水资源。

此外，供应链韧性已成为采购议程的首要议题。业界对此作出了回应，在某些领域整合了供应商，在其他领域则建立了更深的伙伴关係关係，供应商提供整合系统、检验支援和库存管理服务。这种转变促使生物製造商重新评估供应商选择标准、技术转移管治模式和投资重点，以平衡短期敏捷性和长期业务永续营运。

全面评估 2025 年美国预期关税将如何影响一次性生物製程供应链、筹资策略和成本结构

美国预计2025年实施的关税和贸易政策调整可能会对一次性供应链产生连锁反应，影响筹资策略和库存管理，但不会改变一次性产品的基本价值提案。关税主导的成本压力可能促使製造商重新考虑其供应商多元化策略，尽可能优先考虑国内采购方案，并协商签订长期供应协议以平滑价格波动。此类调整可能会导致前置作业时间发生变化，并更加重视二级供应商的资格，以保持连续性。

重点，企业可以透过调整采购策略来应对，例如增加关键零件的本地库存缓衝、转向拥有区域製造地的供应商，或修改合约以纳入与贸易措施相关的价格调整机制。虽然这些战术性应对措施有助于降低风险，但可能会增加营运成本需求并使物流变得复杂。策略性因应措施可以包括投资关键次组件的本地组装能力，或深化与能够提供双重采购保证或专有材料检验的等效产品的供应商的伙伴关係伙伴关係。

监管和合规考量也与应对关税息息相关。跨境采购时，企业必须确保物料可追溯性、分析证书要求以及变更控管程序的稳健性。积极主动地将供应链管治与预期政策情境结合的企业将保持更高的营运韧性，并降低生产中断的风险。最终，关税将影响成本结构和采购选择，但最成功的企业将贸易措施视为更广泛的韧性和供应商管理策略中的变数。

深度细分情报，揭示产品、工作流程、应用程式和最终用户的区别，从而推动采购、部署和创新的优先级

要了解需求和部署模式，需要采用细緻的细分方法，将产品、工作流程、应用和最终用户与采购和技术优先顺序保持一致。从产品角度来看，生物反应器、层析法系统、过滤系统以及混合、储存和填充系统等设备和工厂组件是资本和整合规划的核心。生物反应器的尺寸范围从1000公升以下到1001公升、2000公升以及2000公升以上，这会影响製程设计和供应链的复杂性。袋子、探头和感测器、采样系统、管道、过滤器、连接器和传输系统等简单和周边组件对于运行可靠性至关重要，其中探头和感测器涵盖电导率、流量、氧气、pH值、压力和温度测量。细胞培养系统和注射器等营运设备类别具有独特的采购週期和检验路径，这些与设施设计选择相交叉。

从工作流程阶段的角度来看，上游工程、下游、填充和表面处理工程以及品管与分析之间的差异决定了组织如何分配资本和技术资源。上游工程通常要求密闭性、无菌性和感测器整合等，而下游流程则强调净化能力、一次性层析法和过滤耗材等。此外，品管工作流程需要有效的采样、分析和可追溯性，以满足监管要求。

无菌填充、细胞培养、过滤、混合、纯化、取样和储存对材料、相容性测试和操作员培训的要求各不相同。最终用户涵盖製药和生物技术公司、学术和研究机构、契约製造和研究组织，其实施方法的风险状况、检验能力和预算限制各不相同。结合这些细分维度，可以揭示供应商应将产品开发重点放在哪里，整合商应如何配置其係统，以及为什么买家在选择一次性解决方案时必须平衡技术相容性、法规遵循和服务承诺。

美洲、欧洲、中东和非洲以及亚太地区的招聘趋势、法规环境和生产能力的详细展望

每个地区的驱动因素将显着不同地影响其应用、法规和供应链设计，因此需要高阶主管根据地理丛集客製化策略。在美洲，强大的製造外包网络、成熟的法律规范以及丛集的集中，正在推动抛弃式在临床和商业製造领域的快速应用。北美公司往往优先考虑临床速度和整合供应商关係，青睐那些提供承包系统和验证支援的供应商。

欧洲、中东和非洲地区监管体係错综复杂，高度重视永续性和生命週期评估。严格的监管和日益增长的环境影响担忧，迫使相关人员在一次性和可重复使用系统之间进行权衡，这通常鼓励采用将一次性用品与集中式公用事业和废弃物管理策略相结合的混合方案。该地区也积极开展公私倡议，旨在增强製造业的韧性，并拓展本地在先进疗法方面的能力。

受产能快速扩张、政府支持的生物製造计划以及契约製造数量的成长推动，亚太地区呈现出多样化的采用模式。对本地生产的投资不断增加以及缩短供应链的愿望，正在推动与能够进行本地生产和本地组装的供应商建立合作伙伴关係，以满足产量和资格确认时间表。在所有地区，监管协调工作和跨境供应链规划对于有效扩大一次性产品的部署仍然至关重要。

竞争格局：重点介绍推动创新、伙伴关係和整合的领先製造商、系统整合商和服务供应商

一次性生物製程的竞争态势体现出一种连续性，从专业元件供应商到全方位系统整合商和服务供应商。大型设备製造商持续投资于强大的一次性平台，同时扩展感测器和分析能力，以满足流程视觉化和法规遵循的需求。同时，越来越多的利基供应商专注于高效能耗材，例如一次性过滤介质、专用连接器和先进的管材；这些公司在技术差异化和与旧有系统的有效相容性方面竞争。

服务供应商和承包商越来越多地透过提供检验支援、库存管理和组装服务来加入价值链，从而减轻买家的负担。这种趋势正在模糊传统的供应商与客户之间的界限，企业正在寻求包含安装、培训和生命週期支援的捆绑式服务。伙伴关係和策略联盟日益普遍，技术交叉授权和共同开发契约加快了整合解决方案的上市时间。

最具活力的公司将卓越的工程技术与支援法规提交和持续供应的能力相结合。能够展示严格的品质系统、记录的可追溯性和强大的售后服务的公司，能够更好地建立持久的商业关係。对于负责人而言，评估供应商的能力不仅需要评估产品效能，还需要评估供应商的全球布局、检验套件以及在延长的产品生命週期内支援多站点部署的准备。

为行业领导者提供可行的策略建议，以优化供应链、加速采用并使商业模式与不断发展的一次性使用动态保持一致

领导者应采取平衡的方法，保持灵活性，确保供应的连续性，并使技术选择与监管义务一致。首先要建立跨职能管治，将采购、品质、工程和营运部门整合在一起，全面评估一次性产品的采用决策。此管治应规范供应商合格标准、变更管理触发机制以及关键零件的应急计划，以降低意外中断的风险。

其次，尽可能优先考虑双重采购和区域供应商关係，以降低贸易和物流风险，同时协商包含服务水准预期和检验交付成果的长期承诺。投资内部整合和资格确认能力，避免合作伙伴交接成为瓶颈。开发内部专业知识（例如一次性组装、共用公用设施清洁和分析）的组织可以缩短部署週期并减少外部依赖。

最后，将永续性和生命週期分析融入采购决策中，确定一次性用品在哪些方面能够显着降低能源、水或污染风险，以及混合模式在哪些方面能够带来最佳的整体效益。鼓励供应商提供详细的材料声明和物料输送方案，并将这些考虑纳入资本计画和供应商记分卡，以推动整个供应体系的持续改进。

调查方法概述：描述报告研究结果所依据的主要和次要研究方法、检验方法和分析框架

这项研究采用了混合方法，结合了初步研究、供应商和最终用户分析以及严格的二手资料检验，以确保分析反映商业现实。初步研究包括与不同组织的技术负责人、采购主管和营运经理进行结构化讨论，以了解影响一次性产品采用的决策驱动因素、痛点和切实可行的解决方案。这些第一手的见解构成了以技术就绪性、供应链韧性和监管考量为重点的主题分析的基础。

二次研究包括针对性地审查技术文献、标准出版物和监管指南文件，以检验技术声明并绘製通用的资格认证路径。数据三角测量和交叉检验步骤确保报告的趋势代表广泛的行业情绪，而不是孤立的经验。调查方法也运用情境分析来探讨采购、关税和区域变数如何与业务重点相互影响。

品质保证流程包括专家同行评审和最终编辑，重点关注技术准确性和清晰度。最终的分析框架将策略要务与营运行动相联繫，并为内部基准基准化分析和供应商评估提供可重复的依据，从而为决策者提供支援。

对不断发展的一次性生物製程系统中指导高阶主管决策的策略要务和营运要点的最终综合

一次性生物製程具有操作灵活性、污染控制和模组化扩充性等极具吸引力的特性，但要充分发挥其潜力，需要严格的供应商管治和系统性规划。成功的实施者会结合技术评估、策略性供应商参与和强大的验证框架，使製程设计选择与监管和业务目标保持一致。结论部分总结了报告的核心主题，并强调了最有效降低风险和加速效益实现的优先行动。

随着企业不断完善其一次性系统方案，对供应链弹性、本地监管细节以及整合服务产品的关注将决定领导者与追随者之间的差异。高阶主管应将向一次性用品的过渡视为一项涵盖采购、品质、工程和永续性议题的系统性变革，而非一系列的点式采购。透过週详的规划以及对人员和流程的有针对性的投资，一次性技术的营运效益得以实现，同时又能维持合规性、可预测性和成本控制。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 一次性生物反应器在基因和细胞治疗规模化环境中的快速应用
  • 将线上感测器和数位分析整合到一次性生物处理系统中
  • 制定一次性生物製程耗材的永续处置和回收策略
  • 扩展一次性技术以减少大规模单株抗体生产中的停机时间
  • 全球生物製药市场一次性系统检验的监管协调挑战
  • 供应链中断对持续生物製造所需的一次性零件供应的影响
  • 混合不銹钢和一次性平台的出现，实现了灵活、即插即用的生物生产
  • 使用新型聚合物材料改善一次性系统中的萃取物和可浸出特性
  • 一次性过滤过滤技术的进步提高了病毒去除率和产品纯度
  • 学术界和工业界合作伙伴合作开发模组化一次性平台

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

8. 一次性生物製程市场（依产品类型）

  • 设备和设施
    • 生物反应器
      • 1001L至2000L
      • 2000L以上
      • 最大1000公升
    • 层析法系统
    • 过滤系统
    • 混合、储存和填充系统
    • 泵浦
  • 简单和外围元素
    • 包包
    • 探头和感测器
      • 电导率感测器
      • 流量感测器
      • 氧气感测器
      • pH感测器
      • 压力感测器
      • 温度感测器
    • 采样系统
    • 管道、过滤器、连接器、传输系统
  • 工作设备
    • 细胞培养系统
    • 注射器

9. 一次性生物製程市场（依工作流程阶段）

  • 下游加工
  • 灌装和表面处理工程
  • 品管与分析
  • 上游处理

10. 一次性生物製程市场生物加工模式

  • 批次
  • 流体化床
  • 灌注

第 11 章一次性生物製程市场（按应用）

  • 无菌灌装
  • 细胞培养
  • 滤
  • 混合物
  • 纯化
  • 取样
  • 贮存

12. 一次性生物製程市场（依最终用户）

  • 学术研究机构
  • 契约製造和研究组织
  • 製药和生物技术公司

13. 一次性生物製程市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

14. 一次性生物製程市场（依类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 一次性生物製程市场（依国家）

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Sartorius AG
    • Thermo Fisher Scientific Inc.
    • Agilitech
    • Aseptic Group
    • Avantor, Inc.
    • Bionet Servicios Tecnicos SL
    • BioPharma Dynamics Ltd.
    • CellBios Healthcare & Lifesciences Pvt. Ltd.
    • Compagnie de Saint-Gobain
    • Corning Incorporated
    • Cytiva by Danaher Corporation
    • Entegris, Inc.
    • Eppendorf SE
    • Foxx Life Sciences
    • Freudenberg Group
    • Getinge AB
    • Kuehne+Nagel International AG
    • Lonza Group AG Ltd.
    • Meissner Corporation
    • Merck KGaA
    • Mettler-Toledo International Inc.
    • Parker-Hannifin Corporation
    • PBS Biotech, Inc.
    • PharmNXT Biotech
    • PSG Dover by Dover Corporation
    • Repligen Corporation
    • SaniSure
    • Satake Multimix Corporation
    • Single Use Support GmbH
    • Tekni-Plex, Inc.
    • Watson-Marlow Fluid Technology Solutions by Spirax Group PLC
    • AdvantaPure by NewAge Industries
Product Code: MRR-431752EA4978

The Single-use Bioprocessing Market is projected to grow by USD 59.77 billion at a CAGR of 16.19% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 17.99 billion
Estimated Year [2025] USD 20.81 billion
Forecast Year [2032] USD 59.77 billion
CAGR (%) 16.19%

Executive introduction to single-use bioprocessing technologies and market dynamics that frame strategic decisions for biomanufacturing leaders worldwide

Single-use bioprocessing has matured from an experimental approach into a core manufacturing paradigm for biologics development and commercial production. Over recent years, technological refinements, regulatory acceptance of disposable technologies, and shifting operational priorities have accelerated interest across developers, contract service providers, and established pharmaceutical manufacturers. This introduction outlines the context for why disposable systems matter now: they reduce cross-contamination risk, enable faster campaign turnaround, and offer modularity that supports flexible manufacturing footprints.

As organizations balance the need for speed with stringent quality controls, single-use solutions present trade-offs that require careful evaluation. Capital planning, material supply reliability, and integration with existing stainless-steel assets present practical considerations that shape implementation timelines. The introduction also previews themes that recur throughout the analysis, including lifecycle sustainability, digital instrumentation and sensors, fill-finish decentralization, and the evolving role of suppliers as system integrators rather than component vendors.

Readers will find that appreciating the technology not only in isolation but as part of a broader biomanufacturing ecosystem clarifies where value accrues and where risks remain. Subsequent sections build on this foundation by examining the transformative shifts driving adoption, the implications of changing trade policy, the nuanced segmentation of demand, and the regional and competitive dynamics executives must weigh when defining their single-use strategies.

Emerging technological and operational inflection points reshaping single-use bioprocessing including digital integration, modular design, and sustainability drivers

The single-use bioprocessing landscape is undergoing transformative shifts driven by converging technological, regulatory, and commercial forces. Advances in materials science and sensor miniaturization have improved the reliability and analytics available within disposable assemblies, enabling closer process control and more reproducible outcomes. At the same time, digital integration-through improved connectivity, embedded probes, and remote monitoring-has made single-use systems compatible with modern automation frameworks, thus lowering the barrier to deployment in regulated production environments.

Operational models are also shifting. Manufacturers increasingly prefer modular, skidded solutions that can be scaled horizontally to meet variable demand rather than investing in large fixed-capacity stainless-steel facilities. This change supports fast product lifecycle transitions and contract manufacturing arrangements where rapid changeover and near-term flexibility matter most. Sustainability concerns and lifecycle assessment methodologies are placing new emphasis on material reuse where feasible, while also recognizing the energy and water savings that disposables can deliver over certain process footprints.

Moreover, supply chain resilience has moved to the top of procurement agendas. The industry is responding with supplier consolidation in some segments and with deeper partnerships in others, where vendors provide integrated systems, validation support, and inventory management services. These shifts create an imperative for biomanufacturers to reassess vendor selection criteria, governance models for technology transfer, and investment priorities that balance short-term agility with long-term operational continuity.

Comprehensive assessment of how United States tariff measures anticipated in 2025 could affect supply chains, sourcing strategies, and cost structures across single-use bioprocessing

Anticipated tariff actions and trade policy adjustments in the United States for 2025 have the potential to reverberate through single-use supply chains, influencing sourcing strategies and inventory management without altering the underlying value proposition of disposables. Tariff-driven cost pressures can prompt manufacturers to revisit their vendor diversification strategies, prioritize domestic sourcing options where feasible, and negotiate longer-term supply agreements to smooth price volatility. These adjustments, in turn, can alter lead times and increase emphasis on qualification of secondary suppliers to preserve continuity.

Importantly, companies may respond by adapting procurement tactics: increasing local inventory buffers for critical components, shifting to suppliers with regional manufacturing footprints, or revising contracts to include price adjustment mechanisms tied to trade measures. Such tactical responses help reduce exposure but can increase working capital requirements and complicate logistics. Strategic responses can include investing in local assembly capability for critical subassemblies or deepening partnerships with suppliers who can provide dual-sourcing assurances and validated equivalents for proprietary materials.

Regulatory and compliance considerations also intersect with tariff responses. When sourcing shifts across borders, companies must ensure that material traceability, certificate of analysis requirements, and change control procedures remain robust. Firms that proactively align their supply chain governance with expected policy scenarios will maintain higher operational resilience and reduce the risk of production disruption. Ultimately, while tariffs influence cost structures and sourcing choices, the most successful organizations will treat trade measures as one variable within a broader resilience and supplier management strategy.

Deep segmentation intelligence revealing product, workflow, application, and end-user distinctions that determine procurement, deployment, and innovation priorities

Understanding demand and deployment patterns requires a nuanced segmentation approach that aligns products, workflows, applications, and end users with procurement and technical priorities. From a product perspective, apparatus and plants including bioreactors, chromatography systems, filtration systems, mixing, storage, and filling systems occupy the core of capital and integration planning; bioreactor sizing choices from up to 1000L through 1001L to 2000L and above 2000L influence process design and supply chain complexity. Simple and peripheral elements such as bags, probes and sensors, sampling systems, along with tubing, filters, connectors, and transfer systems are essential to operational reliability, with probes and sensors covering conductivity, flow, oxygen, pH, pressure, and temperature measurement. Work equipment categories such as cell culture systems and syringes present their own procurement cycles and validation pathways that intersect with facility design choices.

When viewed through the lens of workflow stage, distinctions between upstream processing, downstream processing, fill-finish operations, and quality control and analytics determine how organizations allocate capital and technical resources. Upstream decisions often drive requirements for containment, sterility, and sensor integration, while downstream choices emphasize purification capacity and single-use chromatography and filtration consumables. Fill-finish operations necessitate robust aseptic strategies and equipment compatibility with closed-system disposables, and quality control workflows require validated sampling, analytics, and traceability to meet regulatory expectations.

Application-driven segmentation further refines priorities: aseptic filling, cell culture growth, filtration, mixing, purification, sampling, and storage each impose distinct demands on materials, compatibility testing, and operator training. End users, ranging from academic and research institutes to contract manufacturing and research organizations, as well as pharmaceutical and biotechnology companies, approach adoption with differing risk profiles, validation capabilities, and budgetary constraints. Together, these segmentation axes reveal where suppliers should focus product development, how integrators should configure systems, and why purchasers must balance technical fit, regulatory readiness, and service commitments when selecting single-use solutions.

Granular regional perspectives on adoption trajectories, regulatory environments, and capacity trends across the Americas, Europe, Middle East & Africa, and Asia-Pacific

Regional dynamics shape adoption, regulation, and supply chain design in materially different ways, requiring executives to tailor strategies for each geographic cluster. In the Americas, strong contract manufacturing networks, a mature regulatory framework, and a concentration of biotech clusters drive rapid adoption of disposables for both clinical and commercial manufacturing. North American organizations tend to emphasize speed to clinic and integrated supplier relationships, which favors vendors offering turnkey systems and validation support.

Europe, Middle East & Africa presents a complex regulatory mosaic and a high focus on sustainability and lifecycle assessment. Regulatory stringency combined with heightened attention to environmental impact pushes stakeholders to evaluate trade-offs between disposables and reusable systems, often prompting hybrid approaches that pair disposables with centralized utilities and waste management strategies. The region also demonstrates active public-private initiatives to bolster manufacturing resilience and to expand local capability in advanced therapies.

Asia-Pacific exhibits diverse adoption patterns driven by rapid capacity expansion, government-supported biomanufacturing initiatives, and a growing base of contract manufacturers. Increasing investment into local production and the desire to shorten supply chains encourage partnerships with suppliers capable of regional manufacturing or local assembly to meet throughput and qualification timelines. Across all regions, regulatory harmonization efforts and cross-border supply chain planning remain pivotal to scaling single-use deployments efficiently.

Competitive landscape synthesis highlighting leading manufacturers, system integrators, and service providers driving innovation, partnerships, and consolidation dynamics

Competitive dynamics in single-use bioprocessing reflect a continuum from specialized component suppliers to full-scope systems integrators and service providers. Leading equipment manufacturers continue to invest in robust disposable platforms while expanding sensor and analytics capabilities to meet demand for process visibility and regulatory compliance. At the same time, a growing number of niche suppliers focus on high-performance consumables such as single-use filtration media, specialized connectors, and advanced tubing materials; these firms compete on technical differentiation and validated compatibility with legacy systems.

Service providers and contract organizations increasingly participate in the value chain by offering validation support, inventory management, and assembly services that reduce purchaser burden. This trend blurs traditional supplier-customer boundaries as companies seek bundled offerings that include installation, training, and lifecycle support. Partnerships and strategic alliances are common, with technology cross-licensing and co-development agreements accelerating time-to-market for integrated solutions.

The fastest-moving companies combine engineering excellence with an ability to support regulatory submissions and supply continuity. Firms that can demonstrate rigorous quality systems, documented traceability, and robust after-sales service establish durable commercial relationships. For purchasers, assessing supplier capability now requires evaluating not only product performance but also the supplier's global footprint, validation toolkits, and readiness to support multi-site deployments over extended product lifecycles.

Actionable strategic recommendations for industry leaders to optimize supply chains, accelerate adoption, and align commercial models with evolving single-use dynamics

Leaders should pursue a balanced approach that preserves flexibility, ensures supply continuity, and aligns technical choices with regulatory obligations. Begin by establishing cross-functional governance that brings together procurement, quality, engineering, and operations to evaluate single-use adoption decisions holistically. This governance should codify supplier qualification criteria, change-control triggers, and contingency plans for critical components to reduce the risk of unexpected disruptions.

Next, prioritize dual-sourcing and regional supplier relationships where feasible to mitigate trade and logistic exposures while negotiating long-term commitments that include service-level expectations and validation artifacts. Invest in internal capabilities for integration and qualification so that partner handoffs do not become bottlenecks; organizations that develop in-house expertise in single-use assembly, cleaning of shared utilities, and analytics will shorten deployment cycles and reduce external dependency.

Finally, integrate sustainability and lifecycle analysis into procurement decisions to identify where disposables demonstrably reduce energy, water, or contamination risk, and where hybrid models provide the best total impact. Encourage suppliers to provide detailed material declarations and end-of-life handling programs, and embed those considerations into capital planning and vendor scorecards to drive continuous improvement across the supply base.

Methodological overview explaining primary and secondary research approaches, validation techniques, and analytical frameworks that underpin the report's findings

The research synthesis relies on a mixed-methods approach combining primary interviews, supplier and end-user profiling, and rigorous secondary-source validation to ensure the analysis reflects operational realities. Primary research involved structured discussions with technical leaders, procurement heads, and operations managers across a range of organizations to capture decision drivers, pain points, and practical workarounds that influence single-use adoption. These firsthand insights anchored thematic analysis around technology readiness, supply chain resilience, and regulatory considerations.

Secondary research included targeted reviews of technical literature, standards publications, and regulatory guidance documents to validate technical claims and to map common qualification pathways. Data triangulation and cross-validation steps ensured that reported trends represent broad industry sentiment rather than isolated experiences. The methodology also applied scenario analysis to examine how sourcing, tariff, and regional variables interact with operational priorities, while preserving confidentiality and anonymization for all contributing interviewees.

Quality assurance processes encompassed peer review by subject-matter experts and a final editorial pass focusing on technical accuracy and clarity. The resulting analytical framework supports decision-makers by linking strategic imperatives to operational actions and by providing a reproducible basis for internal benchmarking and supplier evaluation exercises.

Conclusive synthesis of strategic imperatives and operational takeaways to guide executive decisions in the evolving single-use bioprocessing ecosystem

In closing, the imperative for executives is clear: single-use bioprocessing presents a compelling mix of operational flexibility, contamination control, and modular scalability, yet it requires disciplined supplier governance and systemic planning to realize its potential. Successful adopters couple technological evaluation with strategic supplier engagement and robust validation frameworks, thereby aligning process design choices with regulatory and business objectives. The conclusion consolidates the report's central themes and reinforces the priority actions that will most effectively reduce risk and accelerate benefit realization.

As organizations refine their approach to single-use systems, attention to supply chain resilience, regional regulatory nuance, and integrated service offerings will distinguish leaders from followers. Executives should treat the transition to disposables as a programmatic change that spans procurement, quality, engineering, and sustainability agendas rather than a series of isolated purchases. With thoughtful planning and targeted investment in people and processes, the operational advantages of single-use technologies can be achieved while maintaining compliance, predictability, and cost discipline.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rapid adoption of single-use bioreactors in gene and cell therapy scale-up environments
  • 5.2. Integration of inline sensors and digital analytics into disposable bioprocessing systems
  • 5.3. Development of sustainable disposal and recycling strategies for single-use bioprocessing consumables
  • 5.4. Expansion of single-use technologies in large-scale monoclonal antibody manufacturing to reduce downtime
  • 5.5. Regulatory harmonization challenges for single-use systems validation across global biopharma markets
  • 5.6. Impact of supply chain disruptions on availability of single-use components for biomanufacturing continuity
  • 5.7. Emergence of hybrid stainless steel and single-use platforms for flexible plug-and-play bioproduction
  • 5.8. Use of novel polymer materials to improve extractables and leachables profiles in disposable systems
  • 5.9. Advances in single-use downstream filtration to enhance virus removal and product purity
  • 5.10. Co-development of modular single-use platforms by academic and industry partners

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Single-use Bioprocessing Market, by Product Type

  • 8.1. Apparatus & Plants
    • 8.1.1. Bioreactors
      • 8.1.1.1. 1001L to 2000L
      • 8.1.1.2. Above 2000L
      • 8.1.1.3. Upto 1000L
    • 8.1.2. Chromatography Systems
    • 8.1.3. Filtration System
    • 8.1.4. Mixing, Storage, & Filling Systems
    • 8.1.5. Pumps
  • 8.2. Simple & Peripheral Elements
    • 8.2.1. Bags
    • 8.2.2. Probes & Sensors
      • 8.2.2.1. Conductivity Sensors
      • 8.2.2.2. Flow Sensors
      • 8.2.2.3. Oxygen Sensor
      • 8.2.2.4. pH Sensor
      • 8.2.2.5. Pressure Sensors
      • 8.2.2.6. Temperature Sensors
    • 8.2.3. Sampling Systems
    • 8.2.4. Tubing, Filters, Connectors, & Transfer Systems
  • 8.3. Work Equipment
    • 8.3.1. Cell Culture System
    • 8.3.2. Syringes

9. Single-use Bioprocessing Market, by Workflow Stage

  • 9.1. Downstream Processing
  • 9.2. Fill-Finish Operations
  • 9.3. Quality Control & Analytics
  • 9.4. Upstream Processing

10. Single-use Bioprocessing Market, by Bioprocess Mode

  • 10.1. Batch
  • 10.2. Fed-Batch
  • 10.3. Perfusion

11. Single-use Bioprocessing Market, by Application

  • 11.1. Aseptic Filling
  • 11.2. Cell Culture
  • 11.3. Filtration
  • 11.4. Mixing
  • 11.5. Purification
  • 11.6. Sampling
  • 11.7. Storage

12. Single-use Bioprocessing Market, by End User

  • 12.1. Academic & Research Institutes
  • 12.2. Contract Manufacturing Organizations & Contract Research Organizations
  • 12.3. Pharmaceutical & Biotechnology Companies

13. Single-use Bioprocessing Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Single-use Bioprocessing Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Single-use Bioprocessing Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Sartorius AG
    • 16.3.2. Thermo Fisher Scientific Inc.
    • 16.3.3. Agilitech
    • 16.3.4. Aseptic Group
    • 16.3.5. Avantor, Inc.
    • 16.3.6. Bionet Servicios Tecnicos SL
    • 16.3.7. BioPharma Dynamics Ltd.
    • 16.3.8. CellBios Healthcare & Lifesciences Pvt. Ltd.
    • 16.3.9. Compagnie de Saint-Gobain
    • 16.3.10. Corning Incorporated
    • 16.3.11. Cytiva by Danaher Corporation
    • 16.3.12. Entegris, Inc.
    • 16.3.13. Eppendorf SE
    • 16.3.14. Foxx Life Sciences
    • 16.3.15. Freudenberg Group
    • 16.3.16. Getinge AB
    • 16.3.17. Kuehne + Nagel International AG
    • 16.3.18. Lonza Group AG Ltd.
    • 16.3.19. Meissner Corporation
    • 16.3.20. Merck KGaA
    • 16.3.21. Mettler-Toledo International Inc.
    • 16.3.22. Parker-Hannifin Corporation
    • 16.3.23. PBS Biotech, Inc.
    • 16.3.24. PharmNXT Biotech
    • 16.3.25. PSG Dover by Dover Corporation
    • 16.3.26. Repligen Corporation
    • 16.3.27. SaniSure
    • 16.3.28. Satake Multimix Corporation
    • 16.3.29. Single Use Support GmbH
    • 16.3.30. Tekni-Plex, Inc.
    • 16.3.31. Watson-Marlow Fluid Technology Solutions by Spirax Group PLC
    • 16.3.32. AdvantaPure by NewAge Industries

LIST OF FIGURES

  • FIGURE 1. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. SINGLE-USE BIOPROCESSING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. SINGLE-USE BIOPROCESSING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. SINGLE-USE BIOPROCESSING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPARATUS & PLANTS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPARATUS & PLANTS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPARATUS & PLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPARATUS & PLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPARATUS & PLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPARATUS & PLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPARATUS & PLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPARATUS & PLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOREACTORS, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOREACTORS, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOREACTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOREACTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOREACTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOREACTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOREACTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY 1001L TO 2000L, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY 1001L TO 2000L, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY 1001L TO 2000L, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY 1001L TO 2000L, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY 1001L TO 2000L, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY 1001L TO 2000L, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ABOVE 2000L, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ABOVE 2000L, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ABOVE 2000L, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ABOVE 2000L, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ABOVE 2000L, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ABOVE 2000L, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY UPTO 1000L, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY UPTO 1000L, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY UPTO 1000L, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY UPTO 1000L, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY UPTO 1000L, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY UPTO 1000L, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILTRATION SYSTEM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILTRATION SYSTEM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILTRATION SYSTEM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILTRATION SYSTEM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILTRATION SYSTEM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILTRATION SYSTEM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MIXING, STORAGE, & FILLING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MIXING, STORAGE, & FILLING SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MIXING, STORAGE, & FILLING SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MIXING, STORAGE, & FILLING SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MIXING, STORAGE, & FILLING SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MIXING, STORAGE, & FILLING SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PUMPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PUMPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PUMPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PUMPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PUMPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PUMPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SIMPLE & PERIPHERAL ELEMENTS, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SIMPLE & PERIPHERAL ELEMENTS, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SIMPLE & PERIPHERAL ELEMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SIMPLE & PERIPHERAL ELEMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SIMPLE & PERIPHERAL ELEMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SIMPLE & PERIPHERAL ELEMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SIMPLE & PERIPHERAL ELEMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SIMPLE & PERIPHERAL ELEMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BAGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BAGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BAGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BAGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BAGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BAGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PROBES & SENSORS, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PROBES & SENSORS, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PROBES & SENSORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PROBES & SENSORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PROBES & SENSORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PROBES & SENSORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PROBES & SENSORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PROBES & SENSORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CONDUCTIVITY SENSORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CONDUCTIVITY SENSORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CONDUCTIVITY SENSORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CONDUCTIVITY SENSORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CONDUCTIVITY SENSORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CONDUCTIVITY SENSORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FLOW SENSORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FLOW SENSORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FLOW SENSORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FLOW SENSORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FLOW SENSORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FLOW SENSORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY OXYGEN SENSOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY OXYGEN SENSOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY OXYGEN SENSOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY OXYGEN SENSOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY OXYGEN SENSOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY OXYGEN SENSOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PH SENSOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PH SENSOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PH SENSOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PH SENSOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PH SENSOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PH SENSOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRESSURE SENSORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRESSURE SENSORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRESSURE SENSORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRESSURE SENSORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRESSURE SENSORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRESSURE SENSORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TEMPERATURE SENSORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TEMPERATURE SENSORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TEMPERATURE SENSORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TEMPERATURE SENSORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TEMPERATURE SENSORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TEMPERATURE SENSORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, FILTERS, CONNECTORS, & TRANSFER SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, FILTERS, CONNECTORS, & TRANSFER SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, FILTERS, CONNECTORS, & TRANSFER SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, FILTERS, CONNECTORS, & TRANSFER SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, FILTERS, CONNECTORS, & TRANSFER SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, FILTERS, CONNECTORS, & TRANSFER SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORK EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORK EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORK EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORK EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORK EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORK EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORK EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORK EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CELL CULTURE SYSTEM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CELL CULTURE SYSTEM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CELL CULTURE SYSTEM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CELL CULTURE SYSTEM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CELL CULTURE SYSTEM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CELL CULTURE SYSTEM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SYRINGES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SYRINGES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SYRINGES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SYRINGES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SYRINGES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SYRINGES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILL-FINISH OPERATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILL-FINISH OPERATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILL-FINISH OPERATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILL-FINISH OPERATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILL-FINISH OPERATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILL-FINISH OPERATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY QUALITY CONTROL & ANALYTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY QUALITY CONTROL & ANALYTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY QUALITY CONTROL & ANALYTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY QUALITY CONTROL & ANALYTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY QUALITY CONTROL & ANALYTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY QUALITY CONTROL & ANALYTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY UPSTREAM PROCESSING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY UPSTREAM PROCESSING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY UPSTREAM PROCESSING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY UPSTREAM PROCESSING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY UPSTREAM PROCESSING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY UPSTREAM PROCESSING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BATCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BATCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BATCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BATCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BATCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BATCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FED-BATCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FED-BATCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FED-BATCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FED-BATCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FED-BATCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FED-BATCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PERFUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PERFUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PERFUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PERFUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PERFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PERFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ASEPTIC FILLING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ASEPTIC FILLING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ASEPTIC FILLING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ASEPTIC FILLING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ASEPTIC FILLING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ASEPTIC FILLING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CELL CULTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CELL CULTURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CELL CULTURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CELL CULTURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CELL CULTURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CELL CULTURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILTRATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILTRATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILTRATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILTRATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILTRATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILTRATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MIXING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MIXING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MIXING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MIXING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MIXING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MIXING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PURIFICATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PURIFICATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PURIFICATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PURIFICATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PURIFICATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PURIFICATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY STORAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY STORAGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY STORAGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY STORAGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY STORAGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY STORAGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS & CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS & CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS & CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS & CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS & CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS & CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 267. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 268. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 269. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 271. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPARATUS & PLANTS, 2018-2024 (USD MILLION)
  • TABLE 272. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPARATUS & PLANTS, 2025-2032 (USD MILLION)
  • TABLE 273. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOREACTORS, 2018-2024 (USD MILLION)
  • TABLE 274. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOREACTORS, 2025-2032 (USD MILLION)
  • TABLE 275. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY SIMPLE & PERIPHERAL ELEMENTS, 2018-2024 (USD MILLION)
  • TABLE 276. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY SIMPLE & PERIPHERAL ELEMENTS, 2025-2032 (USD MILLION)
  • TABLE 277. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY PROBES & SENSORS, 2018-2024 (USD MILLION)
  • TABLE 278. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY PROBES & SENSORS, 2025-2032 (USD MILLION)
  • TABLE 279. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORK EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 280. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORK EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 281. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2024 (USD MILLION)
  • TABLE 282. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2025-2032 (USD MILLION)
  • TABLE 283. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2024 (USD MILLION)
  • TABLE 284. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2025-2032 (USD MILLION)
  • TABLE 285. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 286. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 287. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 288. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 289. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 290. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 291. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 293. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPARATUS & PLANTS, 2018-2024 (USD MILLION)
  • TABLE 294. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPARATUS & PLANTS, 2025-2032 (USD MILLION)
  • TABLE 295. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOREACTORS, 2018-2024 (USD MILLION)
  • TABLE 296. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOREACTORS, 2025-2032 (USD MILLION)
  • TABLE 297. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY SIMPLE & PERIPHERAL